Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Noema Pharma has raised $147.2M in total funding. The most recent round was Series B. The last funding was announced in December 2024.
Noema Pharma's investors include Sofinnova Partners, Jeito Capital, Polaris Partners, Forbion Capital Partners, EQT Life Sciences.
Noema Pharma is headquartered in Basel, Switzerland.
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Noema Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Noema Pharma — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/noema-pharma. Accessed November 12, 2026.
VCBacked. (2024). Noema Pharma — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/noema-pharma
{{cite web |title=Noema Pharma — Funding & Investors |url=https://www.vcbacked.co/company/noema-pharma |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Noema Pharma? Request a listing update